Deals Of The Week: Pfizer Goes For An IPO
Executive Summary
Pfizer’s strategy is to monetize part of its animal health division while continuing new CEO Ian Read’s increased focus on biopharmaceuticals.
You may also be interested in...
Pfizer’s Redmond Surfs To WebMD, With Consumer Health Future In Mind
Cavan Redmond left his role as Pfizer group president, with responsibility for consumer healthcare, to become CEO of the online health information provider May 31. The pharma veteran sees WebMD at the intersection of enabling consumers and physicians to make health care decisions.
Pfizer’s Redmond Surfs To WebMD, With Consumer Health Future In Mind
Cavan Redmond left his role as Pfizer group president, with responsibility for consumer healthcare, to become CEO of the online health information provider May 31. The pharma veteran sees WebMD at the intersection of enabling consumers and physicians to make health care decisions.
Merck Serono/Dr. Reddy's Biosimilars Deal Includes Co-Commercialization In U.S.
In most of the world, Germany's Merck Serono will have exclusive rights and India’s Dr. Reddy's will receive royalties on the oncology biosimilars which will be developed as part of the collaboration; but in the U.S. and select emerging markets, the Indian company retains co-commercialization rights.